Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kandukuri PL"'
Autor:
Chaudhuri KR; Parkinson Foundation Centre of Excellence, King's College Hospital and Kings College, London, UK. ray.chaudhuri@kcl.ac.uk., Azulay JP; Department of Neurology and Movement Disorders, APHM Timone University Hospital and Institut de Neurosciences de la Timone, AMU-CNRS UMR 7289, Marseilles, France., Odin P; University of Lund, Lund, Sweden., Lindvall S; Parkinson's Europe, Sevenoaks, UK., Domingos J; Parkinson's Europe, Sevenoaks, UK.; Egas Moniz School of Health and Science, Almada, Portugal., Alobaidi A; AbbVie Inc., North Chicago, IL, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Chaudhari VS; AbbVie Inc., North Chicago, IL, USA., Parra JC; AbbVie Inc., North Chicago, IL, USA., Yamazaki T; AbbVie GK, Tokyo, Japan., Oddsdottir J; IQVIA, London, UK., Wright J; Adelphi Real World, Bollington, UK., Martinez-Martin P; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2024 Mar; Vol. 11 (1), pp. 1-11. Date of Electronic Publication: 2024 Jan 09.
Autor:
Pahwa R; University of Kansas Medical Center, Kansas City, Kansas, USA., Merola A; Ohio State University, Wexner Medical Center, Columbus, Ohio, USA., Soileau M; Texas Movement Disorder Specialists, Georgetown, Texas, USA., Alobaidi A; AbbVie Inc., North Chicago, Illinois, USA., Pickard AS; University of Illinois at Chicago, Chicago, Illinois, USA., Kandukuri PL; AbbVie Inc., North Chicago, Illinois, USA., Bao Y; AbbVie Inc., North Chicago, Illinois, USA., Strezewski J; AbbVie Inc., North Chicago, Illinois, USA., Oddsdottir J; IQVIA, London, UK., Xu W; IQVIA, Amsterdam, Netherlands., Standaert D; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2023 Dec; Vol. 38 (12), pp. 2308-2312. Date of Electronic Publication: 2023 Oct 25.
Autor:
Martinez-Martin P; Center for Networked Biomedical Research, Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain. pmm650@hotmail.com., Skorvanek M; Department of Neurology, P. J. Šafárik University, Košice, Slovakia.; Department of Neurology, University Hospital L. Pasteur, Košice, Slovakia., Henriksen T; Movement Disorder Clinic, University Hospital of Bispebjerg, Copenhagen, Denmark., Lindvall S; European Parkinson's Disease Association (EPDA), Sevenoaks, UK., Domingos J; European Parkinson's Disease Association (EPDA), Sevenoaks, UK., Alobaidi A; AbbVie Inc., North Chicago, IL, USA.; University of Illinois at Chicago, Chicago, IL, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Chaudhari VS; AbbVie Inc., North Chicago, IL, USA., Patel AB; AbbVie Inc., North Chicago, IL, USA., Parra JC; AbbVie Inc., North Chicago, IL, USA., Pike J; Adelphi Real World, Adelphi Mill, Bollington, UK., Antonini A; Movement Disorders Unit, Department of Neuroscience, University of Padova, Padua, Italy.
Publikováno v:
Journal of neurology [J Neurol] 2023 Apr; Vol. 270 (4), pp. 2162-2173. Date of Electronic Publication: 2023 Jan 12.
Autor:
Soileau MJ; Texas Movement Disorder Specialists, 204 S. Interstate 35, Suite 103, Georgetown, TX, 78628, USA. msoileau@txmds.net., Pagan FL; Georgetown University Hospital, 3800 Reservoir Rd, NW 7 PHC, Washington, DC, 20007, USA., Fasano A; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.; Division of Neurology, University of Toronto, Toronto, ON, Canada.; Krembil Brain Institute, Toronto, ON, Canada., Rodriguez-Cruz R; Neurology One, 7151 University Blvd Ste 100, Winter Park, FL, 32792, USA., Yan CH; AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064, USA., Gupta NR; AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064, USA., Teigland CL; Inovalon Insights, 4321 Collington Rd, Bowie, MD, 20716, USA., Pulungan Z; Inovalon Insights, 4321 Collington Rd, Bowie, MD, 20716, USA., Schinkel JK; Inovalon Insights, 4321 Collington Rd, Bowie, MD, 20716, USA., Kandukuri PL; AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064, USA., Ladhani OA; AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064, USA., Siddiqui MS; Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC, USA.
Publikováno v:
Neurology and therapy [Neurol Ther] 2023 Apr; Vol. 12 (2), pp. 459-478. Date of Electronic Publication: 2023 Jan 18.
Autor:
Pahwa R; University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA., Aldred J; Selkirk Neurology & Inland Northwest Research, PLLC, 610 S Sherman Suite 201, Spokane, WA 99202, USA., Merola A; Ohio State University, Wexner Medical Center, 480 Medical Center Drive, Columbus, OH 43210, USA., Gupta N; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA., Terasawa E; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Garcia-Horton V; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Steffen DR; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Kandukuri PL; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA., Bao Y; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA., Ladhani O; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA., Yan CH; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA.; University of Illinois at Chicago, 833 S. Wood Street, Chicago, IL 60612, USA., Chaudhari V; AbbVie, Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA., Isaacson SH; Parkinson's Disease and Movement Disorders Center, 951 NW 13th St, Boca Raton, FL 33486, USA.
Publikováno v:
Clinical parkinsonism & related disorders [Clin Park Relat Disord] 2022 Dec 20; Vol. 8, pp. 100181. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2023).
Autor:
Antonini A; Parkinson and Movement Disorders Unit, Department of Neuroscience, Study Center for Neurodegeneration (CESNE), University of Padova, 35128, Padua, Italy. Angelo.antonini@unipd.it., Pahwa R; Medical Center, University of Kansas, Kansas City, KS, USA., Odin P; University of Lund, Lund, Sweden., Isaacson SH; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, USA., Merola A; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Wang L; AbbVie Inc., North Chicago, IL, USA.; Johns Hopkins School of Public Health, Baltimore, MD, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Alobaidi A; AbbVie Inc., North Chicago, IL, USA.; University of Illinois at Chicago, Chicago, IL, USA., Yan CH; AbbVie Inc., North Chicago, IL, USA.; University of Illinois at Chicago, Chicago, IL, USA., Bao Y; AbbVie Inc., North Chicago, IL, USA., Zadikoff C; AbbVie Inc., North Chicago, IL, USA., Parra JC; AbbVie Inc., North Chicago, IL, USA., Bergmann L; AbbVie Inc., North Chicago, IL, USA., Chaudhuri KR; King's College and Parkinson Foundation Centre of Excellence, Kings College Hospital London, London, UK.
Publikováno v:
CNS drugs [CNS Drugs] 2022 Dec; Vol. 36 (12), pp. 1269-1283. Date of Electronic Publication: 2022 Nov 21.
Autor:
Pahwa R; University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. rpahwa@kumc.edu., Aldred J; Selkirk Neurology, Spokane, WA, USA., Gupta N; AbbVie Inc., North Chicago, IL, USA., Terasawa E; Analysis Group, Inc., New York, NY, USA., Garcia-Horton V; Analysis Group, Inc., New York, NY, USA., Steffen DR; Analysis Group, Inc., New York, NY, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Chaudhari VS; AbbVie Inc., North Chicago, IL, USA., Jalundhwala YJ; AbbVie Inc., North Chicago, IL, USA., Bao Y; AbbVie Inc., North Chicago, IL, USA., Kukreja P; AbbVie Inc., North Chicago, IL, USA., Isaacson SH; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, USA.
Publikováno v:
Neurology and therapy [Neurol Ther] 2022 Jun; Vol. 11 (2), pp. 711-723. Date of Electronic Publication: 2022 Feb 22.
Autor:
Soileau MJ; Texas Movement Disorder Specialists, 204 S. Interstate 35, Suite 103, Georgetown, TX, 78628, USA. msoileau@txmds.net., Pagan F; Department of Neurology, Georgetown University Hospital, Washington DC, USA., Fasano A; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.; Division of Neurology, University of Toronto, Toronto, ON, Canada.; Krembil Brain Institute, Toronto, ON, Canada., Rodriguez-Cruz R; Synaptic Precision, Inc, Orlando, FL, USA., Wang L; Johns Hopkins School of Public Health, Baltimore, MD, USA.; AbbVie Inc., North Chicago, USA., Kandukuri PL; AbbVie Inc., North Chicago, USA., Yan CH; AbbVie Inc., North Chicago, USA.; Department of Pharmacy Systems, University of Illinois at Chicago, Chicago, IL, USA., Alobaidi A; AbbVie Inc., North Chicago, USA.; Department of Pharmacy Systems, University of Illinois at Chicago, Chicago, IL, USA., Bao Y; AbbVie Inc., North Chicago, USA., Kukreja P; AbbVie Inc., North Chicago, USA., Oh M; AbbVie Inc., North Chicago, USA.; College of Pharmacy, University of Arizona, Tucson, AZ, USA., Siddiqui MS; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Publikováno v:
Neurology and therapy [Neurol Ther] 2022 Jun; Vol. 11 (2), pp. 851-861. Date of Electronic Publication: 2022 Apr 20.
Autor:
Chaudhuri KR; Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, King's College London, Cutcombe Road, London, SE5 9RT, UK. ray.chaudhuri@kcl.ac.uk., Pickard AS; University of Illinois at Chicago, Chicago, IL, USA., Alobaidi A; University of Illinois at Chicago, Chicago, IL, USA.; AbbVie Inc., North Chicago, IL, USA., Jalundhwala YJ; AbbVie Inc., North Chicago, IL, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Bao Y; AbbVie Inc., North Chicago, IL, USA., Sus J; AbbVie Ltd, Maidenhead, Berkshire, UK., Jones G; AbbVie Ltd, Maidenhead, Berkshire, UK., Ridley C; AbbVie Ltd, Maidenhead, Berkshire, UK., Oddsdottir J; IQVIA, London, UK., Najle-Rahim S; IQVIA, London, UK., Madin-Warburton M; IQVIA, London, UK., Xu W; IQVIA, Amsterdam, The Netherlands., Schrag A; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2022 May; Vol. 40 (5), pp. 559-574. Date of Electronic Publication: 2022 Mar 21.
Autor:
Antonini A; Parkinson and Movement Disorders Unit, Study Centre for Neurodegeneration, Department of Neuroscience, University of Padova, Padova, Italy., Pahwa R; Medical Center, University of Kansas, Kansas, KS, USA., Odin P; University of Lund, Lund, Sweden., Henriksen T; Movement Disorder Clinic, University Hospital of Bispebjerg, Copenhagen, Denmark., Soileau MJ; Texas Movement Disorder Specialists, Georgetown, TX, USA., Rodriguez-Cruz R; Synaptic Precision, Inc, Orlando, FL, USA., Isaacson SH; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, USA., Merola A; Madden Center for Parkinson Disease and Other Movement Disorders, Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Lindvall S; European Parkinson's Disease Association, Sevenoaks, UK., Domingos J; European Parkinson's Disease Association, Sevenoaks, UK.; Grupo de Patologia Médica, Nutrição e Exercício Clínico (PaMNEC) do CiiEM, Almada, Portugal., Alobaidi A; AbbVie Inc., North Chicago, IL, USA.; University of Illinois at Chicago, Chicago, IL, USA., Jalundhwala YJ; AbbVie Inc., North Chicago, IL, USA., Kandukuri PL; AbbVie Inc., North Chicago, IL, USA., Parra JC; AbbVie Inc., North Chicago, IL, USA., Kukreja PK; AbbVie Inc., North Chicago, IL, USA., Onuk K; AbbVie Inc., North Chicago, IL, USA., Bergmann L; AbbVie Inc., North Chicago, IL, USA., Pike J; Adelphi Real World, Adelphi Mill, Bollington, UK., Ray Chaudhuri K; King's College and Parkinson Foundation Centre of Excellence, Kings College Hospital London, London, UK. ray.chaudhuri@kcl.ac.uk.
Publikováno v:
Neurology and therapy [Neurol Ther] 2022 Mar; Vol. 11 (1), pp. 303-318. Date of Electronic Publication: 2022 Jan 11.